| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |